Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Future Perspectives for the Treatment of Diabetes: Importance of a Regulatory Framework.

Tsukamoto K, Cnop M, Mori D, Kume S, Anazawa T, Doi M, Chikazawa K, Matsumaru N.

Ther Innov Regul Sci. 2019 Jul;53(4):535-541. doi: 10.1177/2168479018795854. Epub 2018 Sep 3.

PMID:
30176740
2.

Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective.

Kido K, Matsumaru N, Tsukamoto K.

Ther Innov Regul Sci. 2019 Jul;53(4):472-480. doi: 10.1177/2168479018791136. Epub 2018 Aug 29.

PMID:
30157674
3.

The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States.

Nakayama H, Matsumaru N, Tsukamoto K.

Invest New Drugs. 2018 May 31. doi: 10.1007/s10637-018-0612-y. [Epub ahead of print]

PMID:
29855823
4.

Influence of Expedited Programs in the United States on Oncology Drug Development in Japan.

Tanaka M, Matsumaru N, Tsukamoto K.

Ther Innov Regul Sci. 2019 Mar;53(2):199-206. doi: 10.1177/2168479018769288. Epub 2018 May 6.

PMID:
29732928
5.

Industry Perspective of Pediatric Drug Development in the United States: Involvement of the European Union Countries.

Onishi T, Tsukamoto K, Matsumaru N, Waki T.

Ther Innov Regul Sci. 2018 Jan;52(1):49-56. doi: 10.1177/2168479017716718. Epub 2017 Jun 30.

PMID:
29714619
6.

New quantitative method for evaluation of motor functions applicable to spinal muscular atrophy.

Matsumaru N, Hattori R, Ichinomiya T, Tsukamoto K, Kato Z.

Brain Dev. 2018 Mar;40(3):172-180. doi: 10.1016/j.braindev.2017.12.003.

PMID:
29395660
7.

Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including Japan.

Rokuda M, Matsumaru N, Tsukamoto K.

Clin Ther. 2018 Feb;40(2):284-295. doi: 10.1016/j.clinthera.2017.12.010. Epub 2018 Feb 1.

PMID:
29361305
8.

Evaluation of the Microbiological Efficacy of a Single 2-Gram Dose of Extended-Release Azithromycin by Population Pharmacokinetics and Simulation in Japanese Patients with Gonococcal Urethritis.

Soda M, Ito S, Matsumaru N, Nakamura S, Nagase I, Takahashi H, Ohno Y, Yasuda M, Yamamoto M, Tsukamoto K, Itoh Y, Deguchi T, Kitaichi K.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01409-17. doi: 10.1128/AAC.01409-17. Print 2018 Jan.

9.

Improvement of Pediatric Drug Development: Regulatory and Practical Frameworks.

Tsukamoto K, Carroll KA, Onishi T, Matsumaru N, Brasseur D, Nakamura H.

Clin Ther. 2016 Mar;38(3):574-81. doi: 10.1016/j.clinthera.2016.01.012. Epub 2016 Feb 8.

PMID:
26869192
10.

Effect of enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with sepsis-induced acute respiratory distress syndrome.

Shirai K, Yoshida S, Matsumaru N, Toyoda I, Ogura S.

J Intensive Care. 2015 May 19;3(1):24. doi: 10.1186/s40560-015-0087-2. eCollection 2015.

11.

Preliminary experience with air transfer of patients for rescue endovascular therapy after failure of intravenous tissue plasminogen activator.

Tsujimoto M, Yoshimura S, Enomoto Y, Yamada N, Matsumaru N, Kumada K, Toyoda I, Ogura S, Iwama T.

Neurol Med Chir (Tokyo). 2015;55(3):248-52. doi: 10.2176/nmc.cr.2014-0235. Epub 2015 Feb 20.

Supplemental Content

Loading ...
Support Center